Tue Sep 17 05:12:15 UTC 2024: ## Galderma Showcases Advancements in Dermatology at EADV 2024

**ZUG, Switzerland -** Galderma, a leading dermatology company, announced it will be presenting new data and hosting events at the 33rd European Academy of Dermatology and Venereology (EADV) congress in Amsterdam from September 25-28, 2024. The company will showcase updates from its portfolio, including new data on the monoclonal antibody nemolizumab, highlighting its commitment to advancing dermatology for all skin types.

**Focus on Nemolizumab and Itch Management**

Galderma will present nine abstracts on nemolizumab, including three late-breaking presentations on its durability in prurigo nodularis and its long-term efficacy in atopic dermatitis. The company will also explore the unmet needs in both conditions, particularly emphasizing the impact of itch, a debilitating symptom for many patients.

The event will feature a symposium and an industry hub session dedicated to itch management in atopic dermatitis and prurigo nodularis, with experts discussing innovative approaches and strategies for treating these challenging conditions.

**Addressing Sensitive Skin and Acne**

Galderma will also share insights from its Global Sensitive Skincare Faculty (GSSF), a community of experts dedicated to promoting research on sensitive skin. The GSSF will present findings from its global epidemiological survey, involving over 16,000 subjects, highlighting the importance of addressing this complex condition.

Additionally, the company will showcase its new Skin Quality Assessment Scale, a tool designed to accurately assess and improve skin quality. This will be followed by an industry hub session focused on acne management, where Galderma will share its holistic approach to improving treatment outcomes in acne, acne sequelae, and skin quality.

**Commitment to Innovation and Collaboration**

By presenting new data and engaging with the dermatology community, Galderma underscores its commitment to advancing dermatology science and improving the lives of patients. The company’s presence at EADV 2024 reinforces its leadership position in the field and highlights its dedication to addressing the unique needs of individuals with various skin concerns.

Read More